Dechun Geng

Dr. Dechun Geng


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2021 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
GGGaoran Ge
Gaoran Ge
JBJiaxiang Bai
Jiaxiang Bai
QWQing Wang
Qing Wang
XLXiaolong Liang
Xiaolong Liang
HTHuaqiang Tao
Huaqiang Tao
DGDechun Geng
Dechun Geng

1 October 2020 in Biomaterials
Verified
Journal Article
Closed access
JBJiaxiang Bai
Jiaxiang Bai
HWHuaiyu Wang
Huaiyu Wang
HCHao Chen
Hao Chen
GGGaoran Ge
Gaoran Ge
MWMiao Wang
Miao Wang
DGDechun Geng
Dechun Geng

1 August 2015 in Biomaterials
Verified
Journal Article
Closed access
HSHongguo Shao
Hongguo Shao
JSJi Shen
Ji Shen
MWMingjun Wang
Mingjun Wang
JCJingfu Cui
Jingfu Cui
YWYijun Wang
Yijun Wang
DGDechun Geng
Dechun Geng

1 October 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
ZPZichuan Ping
Zichuan Ping
ZWZhirong Wang
Zhirong Wang
JSJiawei Shi
Jiawei Shi
LWLiangliang Wang
Liangliang Wang
XGXiaobin Guo
Xiaobin Guo
DGDechun Geng
Dechun Geng

1 February 2022 in Bioactive Materials
Verified
Journal Article
Open access
YZYanyan Zheng
Yanyan Zheng
AGAng Gao
Ang Gao
JBJiaxiang Bai
Jiaxiang Bai
QLQing Liao
Qing Liao
Yuzheng WUYuzheng WU
Yuzheng WU
HWHuaiyu Wang
Huaiyu Wang
Polyetheretherketone (PEEK) is a desirable alternative to conventional biomedical metals for orthopedic implants due to the excellent mechanical properties. However, the inherent bioinertness of PEEK contributes to inferior osseointegration of PEEK implants, especially under pathological conditions of osteoporosis. Herein, a programmed surface is designed and fabricated on PEEK to dictate osteoimmunomodulation and bone regeneration sequentially. A degradable hybrid coating consisting of poly(lactide-co-glycolide) and alendronate (ALN) loaded nano-hydroxyapatite is deposited on PEEK and then interleukin-4 (IL-4) is grafted onto the outer surface of the hybrid coating with the aid of N2 plasma immersion ion implantation and subsequent immersion in IL-4 solution. Dominant release of IL-4 together with ALN and Ca2+ during the first few days synergistically mitigates the early acute inflammatory reactions and creates an osteoimmunomodulatory microenvironment that facilitates bone regeneration. Afterwards, slow and sustained delivery of ALN and Ca2+ in the following weeks boosts osteogenesis and suppresses osteoclastogenesis simultaneously, consequently ameliorating bone-implant osseointegration even under osteoporotic conditions. By taking into account the different phases in bone repair, this strategy of constructing advanced bone implants with sequential functions provides customizable and clinically viable therapy to osteoporotic patients.

1 February 2016 in Biomaterials
Verified
Journal Article
Closed access
HYHuilin Yang
Huilin Yang
YXYaozeng Xu
Yaozeng Xu
MZMo Zhu
Mo Zhu
YGYe Gu
Ye Gu
WZWen Zhang
Wen Zhang
DGDechun Geng
Dechun Geng